Option delistings effective August 18th include Q32 Bio Inc (QTTB), Hyperdynamics Corp (HYPD), Bionano Genomics (BNGO), Allurion Technologies Inc (ALUR), Moxian (BVI) Inc (ABTS), Spi Energy Co Ltd (SPIEF), TVARDI THERAPEUTICS INC (TVRD), and ZK International Group Ltd (ZKIN).
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on QTTB:
- Q32 Bio Inc. Advances Alopecia Areata Treatment with Phase 2a Trial of Bempikibart
- Q32 Bio Inc. Reports Continued Losses Amid Development Efforts
- Q32 Bio Appoints New Interim Chief Medical Officer
- Q32 Bio chief medical officer Jason Campagna to depart
- Oxford Biomedica completes acquisition of remaining stake in U.S. subsidiary